# FDA Warning Letter: Innoveix Pharmaceuticals Inc
> 2022-02-08 · Office of Pharmaceutical Quality Operations, Division II · `cdd003798242fe98`
## Letter
- **Company:** Innoveix Pharmaceuticals Inc
- **Posted Date:** 2022-02-08
- **Letter Issue Date:** 2022-01-26
- **Issuing Office:** Office of Pharmaceutical Quality Operations, Division II
## Subject
Compounding Pharmacy/Adulterated Drug Products
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*